Valuation: COMPASS Pathways plc

Market Cap 183.26Cr 158.72Cr 147.96Cr 136.08Cr 256.9Cr 17TCr 259.77Cr 1.74TCr 682.41Cr 8.72TCr 688.29Cr 673.12Cr 29TCr P/E 2026 *
-13.7x
P/E 2027 * -8.65x
Enterprise Value 140.55Cr 121.73Cr 113.48Cr 104.37Cr 197.03Cr 13TCr 199.24Cr 1.33TCr 523.38Cr 6.69TCr 527.89Cr 516.26Cr 22TCr EV / Sales 2026 *
-
EV / Sales 2027 * 20.1x
Free-Float
25.07%
Yield 2026 *
-
Yield 2027 * -
1 day+15.08%
1 week+24.59%
Current month+19.65%
1 month-0.29%
3 months+45.71%
6 months+137.83%
Current year+96.81%
1 week 11.02
Extreme 11.0208
13.65
1 month 10.59
Extreme 10.59
14.6
Current year 4.88
Extreme 4.88
15.4
1 year 3.97
Extreme 3.97
15.4
3 years 2.25
Extreme 2.25
15.4
5 years 2.25
Extreme 2.25
49.52
10 years 2.25
Extreme 2.25
61.69
Manager TitleAgeSince
Chief Executive Officer 61 01/08/2022
Director of Finance/CFO 54 01/03/2024
Chief Tech/Sci/R&D Officer 66 01/05/2024
Director TitleAgeSince
Chairman 74 29/03/2024
Director/Board Member 69 01/04/2020
Director/Board Member 67 01/03/2021
Date Insider Type Main position Quantity % Market Cap.
26/03/26 Free

Chief Executive Officer

5,42,815 0.5658%
11/03/26 Tax

Chief Financial Officer

1,781 0.0019%
02/02/26 Tax

Chief Executive Officer

16,181 0.0169%
Change 5-day change 1-year change 3-year change Capi.($)
+15.08%+24.59%+203.12%+59.20% 183.26Cr
+1.21%-0.53%+4.00%+15.71% 4.86TCr
+1.98%+9.05%+413.94%+532.17% 4.19TCr
+3.44%-4.65%+28.34%+8.81% 3.89TCr
+1.40%+0.10%+6.61%+61.93% 3.72TCr
+2.42%+5.72%+12.38%+44.79% 3.07TCr
-0.16%-3.11% - - 1.61TCr
+2.20%+0.48%+34.71%+127.15% 1.64TCr
+0.72%+2.30%+8.64%+19.52% 1.4TCr
+4.25%-8.23%-1.49%-35.46% 1.26TCr
Average +3.25%+1.76%+78.92%+92.65% 2.58TCr
Weighted average by Cap. +2.03%+0.06%+83.96%+120.31%

Financials

2026 *2027 *
Net sales - 6.58Cr 5.7Cr 5.31Cr 4.89Cr 9.23Cr 625.95Cr 9.33Cr 62Cr 25Cr 313.19Cr 25Cr 24Cr 1.04TCr
Net income -10Cr -8.92Cr -8.31Cr -7.64Cr -14Cr -978.81Cr -15Cr -98Cr -38Cr -489.75Cr -39Cr -38Cr -1.62TCr -21Cr -18Cr -17Cr -16Cr -30Cr -2.02TCr -30Cr -201.61Cr -79Cr -1.01TCr -80Cr -78Cr -3.35TCr
Net Debt -43Cr -37Cr -34Cr -32Cr -60Cr -4.06TCr -61Cr -405.18Cr -159.03Cr -2.03TCr -160.4Cr -156.86Cr -6.73TCr -51Cr -44Cr -41Cr -38Cr -72Cr -4.86TCr -72Cr -485.05Cr -190.38Cr -2.43TCr -192.02Cr -187.78Cr -8.06TCr
Logo COMPASS Pathways plc
Compass Pathways plc is a United Kingdom-based biotechnology company dedicated to accelerating patient access to evidence-based innovation in mental health. The Company is engaged in treating mental health conditions focused on rapid and durable responses through the development of its investigational COMP360 psilocybin treatment. COMP360 is its psilocybin formulation that includes its pharmaceutical-grade polymorphic crystalline psilocybin, optimized for stability and purity. The Company’s initial focus is on treatment-resistant depression (TRD), comprising patients who are inadequately served by the current treatment paradigm. It commenced its Phase III program evaluating its COMP360 psilocybin treatment in TRD. In addition, the Company has ongoing Phase II trials in PTSD and anorexia nervosa. It also provides support to research institutions conducting investigator-initiated studies with COMP360 psilocybin in areas of serious unmet need.
Employees
156
Date Price Change Volume
05/26/05 $13.58 +15.08% 76,82,475
04/26/04 $11.80 +4.89% 23,69,462
03/26/03 $11.25 -0.88% 27,75,323
31/26/31 $11.35 -1.90% 19,86,053
30/26/30 $11.57 +6.15% 19,68,680
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
16
Last Close Price
13.58USD
Average target price
23.75USD
Spread / Average Target
+74.89%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. CMPS Stock